tumors.
5 Diagnosis of ENB tends to occur late in the disease course, most commonly presenting in the second and fifth decades of life as unilateral nasal obstruction and epistaxis. [6] [7] [8] Other presenting symptoms reported in the literature include headache, cheek fullness, proptosis, epiphora, retrobulbar pain, vision changes, infraorbital neuralgia, cranial nerve deficits, olfactory dysfunction, altered mental status, nausea, vomiting, and neuroendocrine abnormalities.
9-11
Traditional first-line treatment for ENB is craniofacial resection (CFR) with postoperative radiation therapy. The goal of surgery is to achieve a gross total resection with histologically negative margins. Although the importance of radiation and chemotherapy remains controversial in the literature, 12, 13 surgical treatment in combination with adjuvant radiation and/or chemotherapy has undeniably improved outcomes since the first description of ENB in the literature in 1924. 8, 12, 14, 15 More recently, the purely endoscopic endonasal approach (EEA) has increased in popularity, proving to be an effective method for ENB resection. This technique offers the benefits of reduced morbidity and mortality compared with traditional CFR while achieving comparable oncologic results. [13] [14] [15] [16] Although critics argue that the endoscopic technique limits the ability to achieve a complete en bloc resection, a partial or unilateral resection may be appropriate in select cases. Here we describe a case of olfactory preservation after a unilateral transcribriform transethmoidal resection of ENB.
Clinical Presentation
A 28-year-old woman presented to the outpatient otolaryngology clinic complaining of chronic bilateral nasal congestion. The patient underwent EEA resection via a unilateral transcribriform transethmoidal approach. The olfactory apparatus (epithelium, cribriform plate, and olfactory bulb) was removed en bloc with the tumor, sectioning the olfactory tract 1 cm posterior to the tumor margin (►Fig. 2). This spared the right olfactory apparatus. Intraoperative frozen pathologic sections (ipsilateral olfactory tract, contralateral olfactory epithelium, cribriform dura and bulb) were obtained to confirm histologically negative surgical margins. A multilayered closure was performed using fascia, rigid buttress, and a vascularized nasoseptal flap with fibrin-based tissue sealant. No intraoperative complications were encountered. Postoperatively, the patient experienced a vigorous aseptic meningitis requiring high-dose steroid therapy for 7 days. Immediate postoperative MRI revealed no evidence of residual tumor, and no adjuvant radiation therapy was prescribed. The patient was maintained on a regimen of nasal hygiene with twice daily nasal saline spray and routine rhinologic follow-up. Nasal debridement occurred on an asneeded basis at 10 days and 3 weeks postoperatively. UPSIT smell testing 17 revealed moderate microsomia at 3 months postoperatively and mild microsomia at 18 months postoperatively. The patient remained disease free at last follow-up of 18 months (►Fig. 3).
Discussion ENB is a rare malignancy with 5-and 10-year survival rates of $ 80% and 50%, respectively. 3, [17] [18] [19] [20] Metastasis is reported at the time of diagnosis in 10 to 33% of cases. 6, 7, [21] [22] [23] [24] Despite high rates of cervical metastases, with adequate treatment, ENB carries a superior prognosis compared with other superior nasal malignancies. 25 First-line treatment for ENB is CFR with postoperative radiation therapy, combining a bifrontal craniotomy and transfacial approach to achieve true en bloc resection. This technique is associated with high morbidity and mortality ranging from 30% to 50%. 26, 27 Potential complications reported in the literature include intracranial hypertension, cerebrovascular accident, pneumocephalus, cerebrospinal fluid (CSF) leak, orbital complications, cosmetic complications, infection, and various systemic complications. 17 More aggressive approaches have been reported, using neoadjuvant concomitant radiation and platinumbased chemotherapy with limited success.
28
Endoscopic-assisted CFR was first described in the 1990s, combining a bifrontal craniotomy with an endoscopic endonasal approach, for ENB resection. In 1999, Stammeberger et al performed a retrospective review of eight EEA ENB resections, with gamma knife adjuvant therapy used in select cases. All patients were found to be alive and disease free after a mean follow-up period of 37.2 months. 32 Castelnuovo reported similar findings with nearly all patients remaining disease free at 38.1 months, demonstrating that a purely EEA approach can achieve histologically negative surgical margins. Of note, among this select group of patients, 90% received adjuvant radiation therapy and one patient received chemotherapy due to advanced disease.
34
Casiano et al support these findings with 80% of patients remaining free of disease at 31 months postoperatively.
29
Several retrospective studies describe similar experiences with the EEA approach, some involving late stage tumors.
8,29
The shorter follow-up times in the EEA studies relative to CFR studies limits comparison of these two approaches. Thorough evaluation of ENB resection techniques requires long-term follow-up because recurrence and metastases have been reported up to 10 years after initial treatment.
35
To date, a handful of investigators have developed ENB classification schemes aimed at guiding surgical therapy and demonstrating varying degrees of prognostic significance. 12 CN (n ¼ 33) . The study revealed a greater rate of gross total resection for EEA cases (98.1%) compared with CFR (81.3%). Negative surgical margins were achieved in 93.8%, 95.8%, and 77.3% of EEA, CN, and CFR cases, respectively. The EEA approach was also associated with a decreased rate of regional metastases and greater survival at last follow-up. These findings support the notion that purely EEA or CN approaches do not result in significantly worse surgical and oncologic outcomes compared with traditional CFR, and they serve as viable alternatives for surgical resection. 38 However, much like the meta-analysis published by Devaiah and colleagues, one must consider the fact that high-grade tumors (Kadish stage C) are frequently treated with open surgical approaches, whereas endoscopic techniques are more often used for lower grade tumors (Kadish stages A and B).
33
Despite the proven utility and benefits of a purely EEA, this technique is not without complication. Historically, postoperative CSF leak has been a concern with ENB, particularly when dural involvement is present. 39, 40 Fortunately, newly developed endoscopic skull base reconstruction techniques have proven to be very effective. A new multilayered closure technique, called the gasket seal, has been used in combination with a vascularized nasoseptal flap for a variety of anterior skull base lesions with zero incidence of CSF leak in select studies. 41 Other potential complications reported in the literature include intraoperative bleeding, orbital hematoma, frontal lobe abscess, epistaxis, and prolonged nasal crusting.
42
Most patients are able to undergo endoscopic resection safely and successfully in the hands of an experienced team of endoscopic neurosurgeons and otolaryngologists. However, patients frequently complain of prolonged nasal crusting during the postoperative period. In a quality of life analysis, 69% and 61% of skull base surgery patients complained of smell disturbance and nasal crusting, respectively.
43 Given the intimate relationship of ENB with the cribriform plate and olfactory nerves, olfactory function is often compromised, both from resection of olfactory epithelium and postoperative radiation-induced atrophic rhinitis. However, olfactory dysfunction can be reduced with the EEA approach relative to traditional CFR. 38 Castelnuovo et al demonstrate that olfactory preservation is possible with EEA approach for en bloc or piecemeal resection. 34 Critics of the endoscopic approach argue that this technique limits the ability to achieve en bloc resection, negatively impacting the rate of oncologic cure. However, one may make the claim that in the hands of an experienced endoscopic surgeon, there is little, if any, difference in the degree of tissue removed via the endoscopic approach compared with CFR. Moreover, the literature supports the notion that piecemeal resection does not necessarily translate to an increased rate of local recurrence.
21,31,44
This case provides further support that olfactory preservation is possible via an EEA in select cases of ENB. Olfactory preservation should be considered as an end objective, particularly in patients with low-grade tumors (Kadish stages A and B) and unilateral disease. Meticulous preoperative planning is necessary for olfactory preservation while achieving a sound oncologic resection. Preoperative MRI and axial and coronal computed tomography imaging must be reviewed to assess the extent of soft tissue invasion and bony erosion. The limitations of the EEA must be taken into consideration as well. For more extensive lesions that invade laterally into the maxillary sinus, pterygomaxillary fissure, or infratemporal fossa, and lesions that involve the soft tissues of the face, traditional CFR may be indicated. Adjuvant radiation therapy can be used in select cases to increase local control. 3, 13, 34, 45, 46 Follow-up care with a rhinologist is necessary to ensure proper wound healing. Additionally, long-term follow-up with direct endoscopic visualization and MRI imaging is advised, regardless of surgical technique, to monitor for local recurrence and metastasis.
Conclusion
Endoscopic endonasal resection of ENB has demonstrated similar oncologic control while reducing postoperative morbidity and mortality over traditional transcranial approaches. This case illustrates the potential to preserve olfaction following en bloc resection of ENB. Further evaluation of surgical technique is required to improve preservation while ensuring adequate oncologic resection. Futures studies must incorporate long-term follow up to adequately assess the rate of oncologic cure compared with traditional approaches.
